While newborns and infants with SLC52A1 variants mainly showed MADD-like symptoms, individuals identified in adulthood were usually asymptomatic apart from a typical biochemical profile. This evidence concerns the gene SLC52A1 and multiple acyl-CoA dehydrogenase deficiency.